Bruce Booth's most recent trade in Kymera Therapeutics Inc was a trade of 231,007 Common Stock done at an average price of $108.1 . Disclosure was reported to the exchange on June 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 108.14 per share. | 26 Jun 2026 | 231,007 | 2,603,048 | - | 108.1 | 24,981,097 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 109.79 per share. | 26 Jun 2026 | 32,624 | 2,570,424 | - | 109.8 | 3,581,789 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 108.14 per share. | 26 Jun 2026 | 32,402 | 493,358 | - | 108.1 | 3,503,952 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 107.57 per share. | 26 Jun 2026 | 28,296 | 2,834,055 | - | 107.6 | 3,043,801 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 114.94 per share. | 26 Jun 2026 | 27,951 | 2,505,362 | - | 114.9 | 3,212,688 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 117.85 per share. | 26 Jun 2026 | 22,046 | 2,464,314 | - | 117.8 | 2,598,121 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 107.76 per share. | 26 Jun 2026 | 19,419 | 2,412,158 | - | 107.8 | 2,092,591 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 107.76 per share. | 26 Jun 2026 | 19,093 | 2,412,747 | - | 107.8 | 2,057,462 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 113.97 per share. | 26 Jun 2026 | 14,913 | 2,533,313 | - | 114.0 | 1,699,635 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 106.63 per share. | 26 Jun 2026 | 14,798 | 2,431,577 | - | 106.6 | 1,577,911 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 106.63 per share. | 26 Jun 2026 | 14,613 | 2,431,840 | - | 106.6 | 1,558,184 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 118.66 per share. | 26 Jun 2026 | 12,390 | 2,451,924 | - | 118.7 | 1,470,197 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 117.09 per share. | 26 Jun 2026 | 12,181 | 2,486,360 | - | 117.1 | 1,426,273 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 110.49 per share. | 26 Jun 2026 | 11,277 | 2,559,147 | - | 110.5 | 1,245,996 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 108.28 per share. | 26 Jun 2026 | 10,848 | 2,401,310 | - | 108.3 | 1,174,621 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 108.28 per share. | 26 Jun 2026 | 10,658 | 2,402,089 | - | 108.3 | 1,154,048 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 111.51 per share. | 26 Jun 2026 | 10,366 | 2,548,781 | - | 111.5 | 1,155,913 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 109.75 per share. | 26 Jun 2026 | 7,968 | 2,393,342 | - | 109.8 | 874,488 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 109.75 per share. | 26 Jun 2026 | 7,833 | 2,394,256 | - | 109.8 | 859,672 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 110.67 per share. | 26 Jun 2026 | 7,723 | 2,385,619 | - | 110.7 | 854,704 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 110.67 per share. | 26 Jun 2026 | 7,602 | 2,386,654 | - | 110.7 | 841,313 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 115.69 per share. | 26 Jun 2026 | 6,821 | 2,498,541 | - | 115.7 | 789,121 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 105.78 per share. | 26 Jun 2026 | 5,549 | 2,446,375 | - | 105.8 | 586,973 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 105.78 per share. | 26 Jun 2026 | 5,471 | 2,446,453 | - | 105.8 | 578,722 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 109.79 per share. | 26 Jun 2026 | 4,562 | 488,796 | - | 109.8 | 500,862 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 107.57 per share. | 26 Jun 2026 | 3,958 | 525,760 | - | 107.6 | 425,762 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 114.94 per share. | 26 Jun 2026 | 3,896 | 479,718 | - | 114.9 | 447,806 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 117.85 per share. | 26 Jun 2026 | 3,069 | 473,996 | - | 117.9 | 361,682 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 107.76 per share. | 26 Jun 2026 | 3,024 | 466,077 | - | 107.8 | 325,866 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 107.76 per share. | 26 Jun 2026 | 2,698 | 466,666 | - | 107.8 | 290,736 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 106.63 per share. | 26 Jun 2026 | 2,318 | 469,101 | - | 106.6 | 247,168 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 106.63 per share. | 26 Jun 2026 | 2,133 | 469,364 | - | 106.6 | 227,442 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 113.97 per share. | 26 Jun 2026 | 2,083 | 483,614 | - | 114.0 | 237,400 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 118.66 per share. | 26 Jun 2026 | 1,729 | 472,267 | - | 118.7 | 205,163 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 117.09 per share. | 26 Jun 2026 | 1,701 | 477,065 | - | 117.1 | 199,170 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 108.28 per share. | 26 Jun 2026 | 1,688 | 464,389 | - | 108.3 | 182,777 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 110.49 per share. | 26 Jun 2026 | 1,579 | 487,217 | - | 110.5 | 174,464 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 108.28 per share. | 26 Jun 2026 | 1,498 | 465,168 | - | 108.3 | 162,203 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 111.51 per share. | 26 Jun 2026 | 1,442 | 485,775 | - | 111.5 | 160,797 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 109.75 per share. | 26 Jun 2026 | 1,239 | 463,150 | - | 109.7 | 135,980 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 110.67 per share. | 26 Jun 2026 | 1,199 | 461,951 | - | 110.7 | 132,693 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 109.75 per share. | 26 Jun 2026 | 1,104 | 464,064 | - | 109.8 | 121,164 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 110.67 per share. | 26 Jun 2026 | 1,078 | 462,986 | - | 110.7 | 119,302 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 115.69 per share. | 26 Jun 2026 | 952 | 478,766 | - | 115.7 | 110,137 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 111.20 per share. | 26 Jun 2026 | 934 | 2,384,685 | - | 111.2 | 103,861 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 111.20 per share. | 26 Jun 2026 | 907 | 2,385,747 | - | 111.2 | 100,858 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 105.78 per share. | 26 Jun 2026 | 848 | 471,419 | - | 105.8 | 89,701 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 105.78 per share. | 26 Jun 2026 | 770 | 471,497 | - | 105.8 | 81,451 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 112.49 per share. | 26 Jun 2026 | 555 | 2,548,226 | - | 112.5 | 62,432 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 111.20 per share. | 26 Jun 2026 | 157 | 461,794 | - | 111.2 | 17,458 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 111.20 per share. | 26 Jun 2026 | 130 | 462,856 | - | 111.2 | 14,456 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 112.49 per share. | 26 Jun 2026 | 78 | 485,697 | - | 112.5 | 8,774 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 6,068 | 6,068 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 120.66 per share. | 23 Jun 2026 | 112,299 | 2,963,607 | - | 120.7 | 13,549,997 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 100.42 per share. | 23 Jun 2026 | 103,688 | 3,357,833 | - | 100.4 | 10,412,349 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 116.53 per share. | 23 Jun 2026 | 81,500 | 3,156,442 | - | 116.5 | 9,497,195 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 115.57 per share. | 23 Jun 2026 | 58,205 | 3,237,942 | - | 115.6 | 6,726,752 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 121.38 per share. | 23 Jun 2026 | 40,774 | 2,922,833 | - | 121.4 | 4,949,148 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 119.71 per share. | 23 Jun 2026 | 37,179 | 3,075,906 | - | 119.7 | 4,450,698 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 127.37 per share. | 23 Jun 2026 | 25,075 | 2,864,885 | - | 127.4 | 3,193,803 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 117.50 per share. | 23 Jun 2026 | 24,268 | 3,132,174 | - | 117.5 | 2,851,490 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 118.60 per share. | 23 Jun 2026 | 19,089 | 3,113,085 | - | 118.6 | 2,263,955 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 120.66 per share. | 23 Jun 2026 | 15,660 | 543,864 | - | 120.7 | 1,889,536 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 100.42 per share. | 23 Jun 2026 | 14,513 | 599,076 | - | 100.4 | 1,457,395 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 101.14 per share. | 23 Jun 2026 | 14,490 | 3,343,343 | - | 101.1 | 1,465,519 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 108.83 per share. | 23 Jun 2026 | 14,351 | 3,318,839 | - | 108.8 | 1,561,819 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 124.61 per share. | 23 Jun 2026 | 11,711 | 2,895,285 | - | 124.6 | 1,459,308 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 116.53 per share. | 23 Jun 2026 | 11,375 | 570,673 | - | 116.5 | 1,325,529 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 123.62 per share. | 23 Jun 2026 | 10,860 | 2,906,996 | - | 123.6 | 1,342,513 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 113.70 per share. | 23 Jun 2026 | 10,215 | 3,305,376 | - | 113.7 | 1,161,446 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 107.30 per share. | 23 Jun 2026 | 9,994 | 3,333,349 | - | 107.3 | 1,072,356 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 114.65 per share. | 23 Jun 2026 | 9,229 | 3,296,147 | - | 114.7 | 1,058,105 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 115.57 per share. | 23 Jun 2026 | 8,389 | 582,048 | - | 115.6 | 969,517 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 121.38 per share. | 23 Jun 2026 | 5,689 | 538,175 | - | 121.4 | 690,531 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 119.71 per share. | 23 Jun 2026 | 5,144 | 559,524 | - | 119.7 | 615,788 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 122.67 per share. | 23 Jun 2026 | 4,977 | 2,917,856 | - | 122.7 | 610,529 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 125.82 per share. | 23 Jun 2026 | 3,716 | 2,891,569 | - | 125.8 | 467,547 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 127.37 per share. | 23 Jun 2026 | 3,507 | 530,069 | - | 127.4 | 446,687 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 117.50 per share. | 23 Jun 2026 | 3,359 | 567,314 | - | 117.5 | 394,683 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 118.60 per share. | 23 Jun 2026 | 2,646 | 564,668 | - | 118.6 | 313,816 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 128.69 per share. | 23 Jun 2026 | 2,197 | 2,862,688 | - | 128.7 | 282,732 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 101.14 per share. | 23 Jun 2026 | 2,029 | 597,047 | - | 101.1 | 205,213 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 108.83 per share. | 23 Jun 2026 | 2,011 | 593,614 | - | 108.8 | 218,857 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 110.30 per share. | 23 Jun 2026 | 1,915 | 3,316,924 | - | 110.3 | 211,225 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 124.61 per share. | 23 Jun 2026 | 1,639 | 534,321 | - | 124.6 | 204,236 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 126.71 per share. | 23 Jun 2026 | 1,609 | 2,889,960 | - | 126.7 | 203,876 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 123.62 per share. | 23 Jun 2026 | 1,517 | 535,960 | - | 123.6 | 187,532 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 113.70 per share. | 23 Jun 2026 | 1,437 | 591,726 | - | 113.7 | 163,387 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 107.30 per share. | 23 Jun 2026 | 1,399 | 595,648 | - | 107.3 | 150,113 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 114.65 per share. | 23 Jun 2026 | 1,289 | 590,437 | - | 114.7 | 147,784 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 99.98 per share. | 23 Jun 2026 | 1,235 | 3,461,521 | - | 100.0 | 123,475 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 111.89 per share. | 23 Jun 2026 | 719 | 3,315,591 | - | 111.9 | 80,449 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 122.67 per share. | 23 Jun 2026 | 698 | 537,477 | - | 122.7 | 85,624 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 110.79 per share. | 23 Jun 2026 | 614 | 3,316,310 | - | 110.8 | 68,025 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 125.82 per share. | 23 Jun 2026 | 522 | 533,799 | - | 125.8 | 65,678 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 129.61 per share. | 23 Jun 2026 | 337 | 2,862,351 | - | 129.6 | 43,679 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 128.69 per share. | 23 Jun 2026 | 305 | 529,764 | - | 128.7 | 39,250 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 110.30 per share. | 23 Jun 2026 | 265 | 593,349 | - | 110.3 | 29,230 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 126.71 per share. | 23 Jun 2026 | 223 | 533,576 | - | 126.7 | 28,256 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 99.98 per share. | 23 Jun 2026 | 173 | 613,589 | - | 100.0 | 17,297 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 108.02 per share. | 23 Jun 2026 | 159 | 3,333,190 | - | 108.0 | 17,175 | Common Stock |